Cargando…
Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
Programmed cell death ligand-1 (PD-L1) binds PD-1 on CD(8+) lymphocytes, inhibiting their cytotoxic action. Its aberrant expression by head and neck squamous cell carcinoma (HNSCC) cells leads to immune escape. Pembrolizumab and nivolumab, two humanized monoclonal antibodies against PD-1, have been...
Autores principales: | Meliante, Piero Giuseppe, Zoccali, Federica, de Vincentiis, Marco, Ralli, Massimo, Petrella, Carla, Fiore, Marco, Minni, Antonio, Barbato, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001329/ https://www.ncbi.nlm.nih.gov/pubmed/36900006 http://dx.doi.org/10.3390/diagnostics13050862 |
Ejemplares similares
-
Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies
por: Meliante, Piero Giuseppe, et al.
Publicado: (2022) -
Head and Neck Squamous Cell Carcinoma Vaccine: Current Landscape and Perspectives
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023) -
Antioxidant Use after Diagnosis of Head and Neck Squamous Cell Carcinoma (HNSCC): A Systematic Review of Application during Radiotherapy and in Second Primary Cancer Prevention
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023) -
Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023) -
Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Proteomic Overview
por: Riccardi, Gabriele, et al.
Publicado: (2022)